DOJ Crackdown Halts Kids’ Gender Drugs

group of schoolchildren running with backpacks
Photo: Monkey Business Images / Shutterstock

The Justice Department forced NYU Langone and UPMC to stop giving puberty blockers, cross-sex hormones, and surgeries to minors — and pay up.

Story Highlights

  • The Department of Justice said NYU Langone and UPMC will end pediatric gender treatments.
  • NYU will pay $8.5 million; UPMC will pay $950,000, according to officials.
  • The agreements resolve probes into possible federal law violations tied to billing.
  • The move fits a wider federal crackdown on youth gender clinics since 2025.

DOJ Agreements End Pediatric Gender Treatments at Two Major Systems

The Department of Justice announced agreements with New York University Langone Hospitals and the University of Pittsburgh Medical Center that end gender-related medical interventions for minors at both systems. The department said the resolutions address potential violations of federal law and require both providers to stop puberty blockers, cross-sex hormones, and surgical procedures for patients under 18. Officials also said the agreements include monetary payments by each hospital system to close the investigations.

Officials put the combined payments near $9.5 million. Reporting identified $8.5 million from NYU Langone and $950,000 from the University of Pittsburgh Medical Center. The Justice Department described the treatments targeted by the agreements and tied the enforcement to potential false billing and coding related to care for minors. The settlements resolve the probes without a court finding of liability and shift clinical policy at both systems going forward.

Financial Terms and Hospital Statements

New York University Langone confirmed a settlement with the Department of Justice and said the deal resolves the investigation and protects patient privacy. The system stated the agreement removes the threat of ongoing enforcement while it ends youth gender interventions. Local reporting in Pittsburgh said the University of Pittsburgh Medical Center agreed to pay $950,000 and likewise halt pediatric gender-related treatments under the deal, citing the same focus on privacy and closure. Each system framed the resolution as finality without admitting wrongdoing.

The Department of Justice highlighted that the agreements require both providers to stop giving puberty blockers, cross-sex hormones, and surgical procedures to minors. That list sets a clear line for future practice standards at the two systems. Federal officials said payment terms accompany the practice changes. Those terms bring this matter in line with other recent settlements involving youth gender clinics in several states since 2025.

Part of a Broader Enforcement Pattern Since 2025

This action matches a broader pattern where the federal government and states use fraud and billing laws to police pediatric gender clinics. In several cases, hospitals faced claims tied to diagnosis codes and claims submitted for services to minors, and they chose settlement over trial. The Department of Justice has announced similar agreements with other health systems and, in some cases, required added spending to treat harms from prior care. These actions increased under President Trump’s second term.

The pattern shows a clear federal priority: stop unproven and risky interventions on children and hold institutions to billing rules. The Cleveland Clinic and other providers reached resolutions that redirected funds and ended youth gender procedures, adding pressure across the industry. Health policy groups also noted that federal rulemaking and oversight flagged widespread billing risks in this area, setting the stage for these settlements and future probes.

Why This Matters to Families and Taxpayers

Parents want guardrails that put children’s safety first. These agreements do that by halting drug and surgical interventions on minors at two large systems. Taxpayers also expect honest billing. The government’s focus on false claims and coding abuses addresses that concern head-on. While the hospitals did not admit wrongdoing, the practice changes and payments signal a clear standard: do not experiment on kids, and do not shift the cost to the public through suspect claims.

What Comes Next for Providers and Policymakers

Hospitals now face a simple choice. Comply with law and policy, or face probes that can lead to heavy costs and sharp limits on practice. More systems could follow NYU Langone and the University of Pittsburgh Medical Center by settling and ending youth gender interventions. Congress and state leaders may also tighten laws on minors’ medical eligibility, consent, and billing. For families, these steps promise more transparency and a return to common-sense care focused on long-term health.

Sources:

townhall.com, justice.gov, ground.news, wpxi.com, nyulangone.org, cbsnews.com, law360.com